GO:0097121 cyclin A1-CDK1 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097121 describes the cyclin A1-CDK1 complex, a heterodimeric serine/threonine protein kinase complex in which cyclin A1 acts as the regulatory subunit and CDK1 as the catalytic subunit.
• Cyclin A1-CDK1 activity is cell-cycle periodic, with cyclin A1 abundance peaking in S and G2 phases and CDK1 providing the kinase engine that drives progression toward mitosis.
• The complex phosphorylates substrates that control DNA replication, centrosome duplication, and mitotic entry, making it a central node in cell-cycle regulation.
• Cyclin A1 is less ubiquitously expressed than cyclin A2 and is most prominent in germ cells and certain cancers, so the cyclin A1-CDK1 complex has specialized rather than purely housekeeping functions.
• Dysregulation of cyclin A1-CDK1 is linked to tumorigenesis, and the complex is a candidate target for chemical inhibition and degradation strategies.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of cyclin A1-CDK1 function in disease and development.
Description
The cyclin A1-CDK1 complex (GO:0097121) is a cellular protein complex composed of cyclin A1 and cyclin-dependent kinase 1 (CDK1). Cyclins are regulatory proteins whose abundance oscillates through the cell cycle, and CDKs are serine/threonine kinases that become catalytically active only upon binding a cyclin partner. In this complex, cyclin A1 serves as the regulatory subunit that recruits and activates CDK1, while CDK1 provides the phosphotransferase activity that modifies downstream substrates. Because CDK1 is the major mitotic kinase and cyclin A1 is a cell-cycle-regulated cyclin, the cyclin A1-CDK1 complex sits at the interface of S-phase progression, G2 checkpoint control, and mitotic entry. Researchers study GO:0097121 because it represents a specific molecular machine rather than a generic kinase activity. The complex is distinct from the more widely expressed cyclin A2-CDK1 and cyclin B-CDK1 complexes, and its unique subunit composition confers substrate specificity and tissue-restricted functions. Understanding cyclin A1-CDK1 assembly, activation, and substrate selection is therefore essential for interpreting cell-cycle phenotypes and for designing targeted interventions in cancer and other proliferative disorders. This article integrates the QuickGO definition of GO:0097121 with verified PubMed literature to summarize the complex's composition, regulation, disease relevance, and the experimental models used to study it.
cyclin A1-CDK1 complex At A Glance
| GO ID | GO:0097121 |
|---|---|
| GO term | cyclin A1-CDK1 complex |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Serine/threonine protein kinase activity directed at cell-cycle substrates, with cyclin A1 as regulatory subunit and CDK1 as catalytic subunit |
| Complex type | Heterodimeric cyclin-CDK complex |
| Cell-cycle timing | Cyclin A1 abundance is periodic, contributing to S/G2-phase and mitotic entry control |
| Catalytic subunit | CDK1 (cyclin-dependent kinase 1) |
| Regulatory subunit | Cyclin A1 |
| Related complexes | Cyclin A2-CDK1, cyclin B-CDK1, and other cyclin-CDK nanomachines |
What Is GO:0097121?
GO:0097121, cyclin A1-CDK1 complex, is defined in QuickGO as a protein complex consisting of cyclin A1 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle, and cyclin-dependent kinases are a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. In practical terms, the cyclin A1-CDK1 complex is a two-subunit enzyme in which cyclin A1 supplies the regulatory and substrate-recognition surface and CDK1 supplies the catalytic kinase domain.
Why Is cyclin A1-CDK1 complex Important in Cell Biology?
The cyclin A1-CDK1 complex is important because it is a dedicated cell-cycle kinase module that links cyclin periodicity to phosphorylation of substrates required for DNA replication, centrosome maturation, and mitotic entry. Unlike broadly expressed cyclin A2, cyclin A1 has restricted expression and specialized roles, so the cyclin A1-CDK1 complex provides a unique entry point for understanding tissue-specific and germ-cell-related cell-cycle control. Its dysregulation is implicated in cancer, and the complex is being explored as a target for inhibitory and degradation-based therapeutic strategies.
• Drives cell-cycle progression by phosphorylating substrates required for S-phase and mitotic entry.
• Provides a specific cyclin-CDK pairing distinct from cyclin A2-CDK1 and cyclin B-CDK1 complexes.
• Contributes to centrosome duplication and mitotic spindle regulation through CDK1-dependent phosphorylation.
• Is cell-cycle periodic, making it a readout for phase-specific progression and checkpoint integrity.
• Is implicated in tumorigenesis, particularly in cancers with altered cyclin A1 expression.
• Is a candidate target for small-molecule CDK inhibitors and targeted protein degradation.
• Serves as a model for studying cyclin-CDK nanomachine assembly and substrate specificity.
• Can be dissected genetically using CRISPR knockout, point mutation, knock-in, and overexpression models.
Core Biology of GO:0097121 cyclin A1-CDK1 complex
Biological Process: What Happens During cyclin A1-CDK1 complex?
In simple terms: The cyclin A1-CDK1 complex is a molecular switch that helps cells move through the cell cycle by adding phosphate tags to other proteins.
During the cell cycle, cyclin A1 abundance rises periodically, allowing it to bind and activate CDK1. The resulting cyclin A1-CDK1 complex phosphorylates serine and threonine residues on substrate proteins, thereby altering their activity, localization, or stability to promote S-phase progression and prepare for mitosis. This process is part of the broader cyclin-CDK kinetic landscape that drives phase-specific cell-cycle progression.
Biological Process: Substrate Phosphorylation and Cell-Cycle Phase Progression
In simple terms: Once assembled, the complex tags specific proteins with phosphate groups, which pushes the cell forward through the cycle.
Cyclin A1-CDK1 phosphorylates substrates involved in DNA replication and centrosome duplication, contributing to the ordered progression from S phase to G2 and then to mitosis. The complex's activity is coordinated with other cyclin-CDK complexes, such as cyclin E-CDK2 and cyclin B-CDK1, to ensure unidirectional cell-cycle transitions.
Cellular Component: Structure and Composition of cyclin A1-CDK1 complex
In simple terms: The complex is made of two proteins: cyclin A1, which holds and directs the enzyme, and CDK1, which does the chemical work.
The cyclin A1-CDK1 complex is a heterodimer in which cyclin A1 provides the regulatory surface that binds and activates CDK1. CDK1 contains the catalytic kinase domain, and its activation requires cyclin binding as well as phosphorylation events on conserved residues. Structural studies of related cyclin-CDK complexes have revealed how cyclin binding remodels the CDK active site to enable substrate phosphorylation.
Cellular Component: Assembly and Activation Steps
In simple terms: The two subunits must find each other and undergo chemical modifications before the complex can work.
Assembly of the cyclin A1-CDK1 complex begins with synthesis and accumulation of cyclin A1 during the cell cycle, followed by binding to CDK1. Activation typically involves phosphorylation of CDK1 at a conserved threonine residue by CDK-activating kinase and dephosphorylation of inhibitory residues by CDC25 phosphatases. The assembled and activated complex is then competent to phosphorylate cell-cycle substrates.
Molecular Function: Catalytic Mechanism and Substrate Recognition
In simple terms: The complex works like a molecular stapler, attaching phosphate groups to target proteins at specific spots.
The molecular function of the cyclin A1-CDK1 complex is serine/threonine protein kinase activity directed at substrates containing consensus phosphorylation motifs. Cyclin A1 contributes to substrate recognition by presenting interaction surfaces that position substrates near the CDK1 catalytic cleft. ATP serves as the phosphate donor, and the reaction transfers the gamma-phosphate of ATP to the hydroxyl group of serine or threonine residues on substrate proteins.
Molecular Function: Regulation by Cofactors and Inhibitors
In simple terms: Other proteins can put the brakes on the complex or help it get into the right place at the right time.
The activity of the cyclin A1-CDK1 complex is modulated by CDK inhibitors such as p21 and p27, which can bind and block the catalytic site. Phosphorylation and dephosphorylation events on CDK1 regulate its activation state, and subcellular localization of cyclin A1 influences where the complex acts. These regulatory layers ensure that cyclin A1-CDK1 activity is confined to the appropriate cell-cycle window.
Key Genes Involved in GO:0097121 cyclin A1-CDK1 complex
The cyclin A1-CDK1 complex involves a core catalytic and regulatory pair plus a network of upstream regulators, substrates, and checkpoint proteins.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCNA1 | Encodes cyclin A1, the regulatory subunit of the complex | Defines the specific identity of GO:0097121 and its tissue-restricted functions |
| CDK1 | Encodes cyclin-dependent kinase 1, the catalytic subunit | Central mitotic kinase; target of inhibitors and degradation strategies |
| CCNA2 | Encodes cyclin A2, a related cyclin that also binds CDK1 | Provides a comparison for cyclin A1-specific functions |
| CCNB1 | Encodes cyclin B1, which forms the mitotic cyclin B-CDK1 complex | Helps distinguish cyclin A1-CDK1 from mitotic CDK1 complexes |
| CCNE1 | Encodes cyclin E, which activates CDK2 during G1/S | Context for phase-specific cyclin-CDK kinetics |
| CDK2 | Encodes CDK2, a related kinase activated by cyclin E and cyclin A | Comparison for CDK1-specific functions |
| CDC25A | Phosphatase that removes inhibitory phosphates from CDKs | Regulates activation of cyclin-CDK complexes |
| CDC25C | Phosphatase involved in mitotic CDK1 activation | Links cyclin A1-CDK1 to mitotic entry control |
| CDKN1A | Encodes p21, a CDK inhibitor | Modulates cyclin A1-CDK1 activity |
| CDKN1B | Encodes p27, a CDK inhibitor | Modulates cyclin A1-CDK1 activity |
| CDK7 | CDK-activating kinase subunit that phosphorylates CDK1 | Required for full activation of CDK1 |
| CCNH | Encodes cyclin H, partner of CDK7 | Part of the CDK-activating kinase module |
| MCM2 | DNA replication licensing factor and CDK substrate | Readout of cyclin A1-CDK1 substrate phosphorylation |
| MCM3 | DNA replication licensing factor and CDK substrate | Readout of cyclin A1-CDK1 substrate phosphorylation |
| PLK1 | Polo-like kinase 1, a mitotic regulator downstream of CDK1 | Connects cyclin A1-CDK1 to mitotic progression |
| AURKA | Aurora kinase A, involved in centrosome maturation | Functional partner in centrosome duplication |
| TP53 | Tumor suppressor that responds to cell-cycle stress | Links cyclin A1-CDK1 dysregulation to cancer pathways |
| RB1 | Retinoblastoma protein, a cell-cycle checkpoint regulator | Context for CDK-dependent cell-cycle control |
How Is cyclin A1-CDK1 complex Regulated?
The cyclin A1-CDK1 complex is regulated at multiple levels. Cyclin A1 abundance is cell-cycle periodic, so the complex assembles only when cyclin A1 accumulates. CDK1 activity is further controlled by activating phosphorylation at a conserved threonine and inhibitory phosphorylation at adjacent residues, with CDC25 phosphatases and CDK-activating kinase opposing each other. CDK inhibitors such as p21 and p27 can bind and inhibit the complex. Subcellular localization and substrate availability also shape where and when cyclin A1-CDK1 acts. Together, these mechanisms ensure that the complex is active only during the appropriate cell-cycle window.
cyclin A1-CDK1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCNA1 | Cancer and germ cell biology | CRISPR knockout and overexpression in cancer cell lines |
| CDK1 | Proliferative disorders and mitotic defects | Point-mutation and inhibitor studies |
| CCNA2 | Cell-cycle dysregulation | Knockout comparison with CCNA1 |
| CDKN1A | Checkpoint dysfunction | Knock-in of phospho-mutants |
| TP53 | Tumorigenesis | Knockout and knock-in models |
Cyclin A1-CDK1 complex in cancer
Altered expression of cyclin A1 and dysregulated CDK1 activity have been associated with tumorigenesis and cancer progression. Because the cyclin A1-CDK1 complex drives cell-cycle progression, its hyperactivity can promote uncontrolled proliferation, and its inhibition is being explored as an anticancer strategy. Targeting cyclin K and related cyclin-CDK complexes has emerged as a therapeutic avenue, highlighting the broader relevance of cyclin-dependent kinases in oncology.
Cyclin A1-CDK1 complex in germ cell and developmental biology
Cyclin A1 is expressed in germ cells and has specialized roles in meiosis and gametogenesis. The cyclin A1-CDK1 complex therefore contributes to developmental processes beyond somatic cell-cycle control, and its disruption may affect fertility and germ cell development.
Cyclin A1-CDK1 complex and cell-cycle checkpoint dysfunction
Loss of checkpoint control involving cyclin A1-CDK1 can lead to genomic instability and inappropriate cell-cycle progression. Because CDK1 is a central mitotic kinase, its dysregulation affects mitotic entry and can contribute to aneuploidy and proliferative disorders.
From cyclin A1-CDK1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does cyclin A1 loss block cell-cycle progression? | CCNA1 CRISPR knockout cell line |
| Does a specific CDK1 phosphorylation site control substrate specificity? | CDK1 point-mutation knock-in |
| Where does cyclin A1-CDK1 localize during the cell cycle? | Tagged knock-in of CCNA1 or CDK1 with fluorescent tag |
| Does cyclin A1 overexpression drive proliferation? | Doxycycline-inducible overexpression cell line |
| Which substrates are phosphorylated by cyclin A1-CDK1? | Knockout plus phosphoproteomics |
| Can chemical inhibitors selectively target cyclin A1-CDK1? | Point-mutation of the ATP-binding pocket |
How to Study the cyclin A1-CDK1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Substrate phosphorylation sites | Identifying cyclin A1-CDK1 substrates |
| Flow cytometry | Cell-cycle distribution | Assessing knockout or overexpression phenotypes |
| Live-cell imaging | Complex localization and dynamics | Tracking cyclin A1-CDK1 during the cell cycle |
| In vitro kinase assay | Catalytic activity and inhibition | Characterizing point mutants and inhibitors |
| RNA-seq | Transcriptional changes | Pathway analysis after knockout |
| CRISPR library screening | Gene essentiality and modifiers | Identifying synthetic lethal partners |
| Co-immunoprecipitation | Protein-protein interactions | Confirming complex assembly |
| Western blotting | Protein abundance and phosphorylation | Validating activation state |
Proteomic and phosphoproteomic analysis
Mass spectrometry-based phosphoproteomics can identify substrates and phosphorylation sites regulated by the cyclin A1-CDK1 complex. Comparing wild-type and knockout cells reveals complex-dependent phosphorylation events.
Cell-cycle profiling and imaging
Flow cytometry and live-cell imaging of fluorescently tagged cyclin A1 and CDK1 can track complex assembly and cell-cycle phase progression. These methods reveal when and where the complex is active.
Biochemical kinase assays
In vitro kinase assays using recombinant cyclin A1-CDK1 and substrate peptides measure catalytic activity and inhibitor sensitivity. Such assays are used to characterize point mutants and small-molecule inhibitors.
Transcriptomic and CRISPR screening approaches
RNA-seq and CRISPR library screens can identify genes that modulate cyclin A1-CDK1 activity or that are required for proliferation in its presence. These approaches link the complex to broader cellular networks.
How CRISPR Can Be Used to Study GO:0097121 cyclin A1-CDK1 complex
Knockout
CRISPR knockout of CCNA1 or CDK1 eliminates the cyclin A1-CDK1 complex and reveals its requirement for cell-cycle progression and proliferation. Knockout models are used to identify complex-dependent substrates and phenotypes.
Point Mutation
Point mutations in CDK1 or CCNA1 can be introduced to dissect catalytic activity, substrate recognition, and regulatory phosphorylation sites. Such models help distinguish kinase-dependent from scaffold functions.
Knock-in
Knock-in of tagged or fluorescent versions of cyclin A1 and CDK1 allows visualization and purification of the endogenous complex. Knock-in of disease-associated variants can model human mutations.
Overexpression
Overexpression of cyclin A1 or CDK1 can drive proliferation and transform cells, providing a model for cyclin A1-CDK1-driven tumorigenesis. Inducible systems allow temporal control of complex levels.
How EDITGENE Supports cyclin A1-CDK1 complex Research
Researchers studying cyclin A1-CDK1 complex-related genes often need to determine whether a candidate gene is causally involved in cell-cycle regulation, proliferation, or disease. EDITGENE provides CRISPR-based cell model services that enable precise genetic manipulation of CCNA1, CDK1, and related genes.
Contact EDITGENE today to design your custom CRISPR model for cyclin A1-CDK1 complex research.
Frequently Asked Questions About cyclin A1-CDK1 complex
What is the cyclin A1-CDK1 complex?
The cyclin A1-CDK1 complex (GO:0097121) is a protein complex consisting of cyclin A1 and cyclin-dependent kinase 1 (CDK1), which functions as a serine/threonine kinase during the cell cycle.
What genes are involved in the cyclin A1-CDK1 complex?
The core genes are CCNA1 (cyclin A1) and CDK1 (cyclin-dependent kinase 1), with regulators including CDC25 phosphatases, CDK7, and CDK inhibitors such as p21 and p27.
What does GO:0097121 mean?
GO:0097121 is the Gene Ontology identifier for the cyclin A1-CDK1 complex, classified under the cellular_component ontology.
When is the cyclin A1-CDK1 complex active?
Cyclin A1 abundance is periodic, so the complex assembles and acts during specific cell-cycle windows, contributing to S-phase and mitotic entry control.
How is the cyclin A1-CDK1 complex regulated?
It is regulated by cyclin A1 periodicity, CDK1 activating and inhibitory phosphorylation, CDC25 phosphatases, and CDK inhibitors such as p21 and p27.
What diseases are linked to cyclin A1-CDK1?
Dysregulation of cyclin A1 and CDK1 has been associated with cancer and proliferative disorders, and the complex is a candidate therapeutic target.
How can I study the cyclin A1-CDK1 complex in the lab?
Common approaches include CRISPR knockout, point mutation, knock-in, overexpression, phosphoproteomics, kinase assays, and cell-cycle imaging.
Is cyclin A1-CDK1 the same as cyclin A2-CDK1?
No, cyclin A1 and cyclin A2 are distinct cyclins with different expression patterns and functions, although both can bind CDK1.
What substrates does cyclin A1-CDK1 phosphorylate?
Substrates include proteins involved in DNA replication and centrosome duplication, such as MCM proteins and mitotic regulators.
Can CRISPR be used to model cyclin A1-CDK1 dysfunction?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect cyclin A1-CDK1 function and disease relevance.
Conclusion
The cyclin A1-CDK1 complex (GO:0097121) is a specialized cyclin-CDK module that couples cyclin A1 periodicity to CDK1-driven phosphorylation of cell-cycle substrates. Its composition, regulation, and disease links make it a valuable target for both mechanistic and translational research. CRISPR-based models and modern omics methods provide powerful tools to dissect its functions in health and disease.
References
- 1. Zhang W et al.. 2026. Cyclin-E/A/CDK1/2 Kinetic Landscapes Drive Cell Cycle Phase-Specific Progression and Guide Cyclin-E Degradation Strategy.. J Chem Inf Model 66(6):3188-3205 PMID: 41801818
- 2. Palmer N et al.. 2020. Less-well known functions of cyclin/CDK complexes.. Semin Cell Dev Biol 107:54-62 PMID: 32386818
- 3. Koliopoulos MG et al.. 2022. Cell cycle regulation by complex nanomachines.. FEBS J 289(17):5100-5120 PMID: 34143558
- 5. McGeoch AJS et al.. 2026. Cryo-EM structures of the CDK11-cyclin L-SAP30BP complex reveal mechanisms of CDK11 regulation.. Nat Commun 17(1) PMID: 42034640
- 6. Xiao Y et al.. 2023. Coming of Age: Targeting Cyclin K in Cancers.. Cells 12(16) PMID: 37626854
- 8. Jackman MR et al.. 1997. Cyclins and the G2/M transition.. Cancer Surv 29:47-73 PMID: 9338096
